ENDRA Life Sciences  logo
ENDRA Life Sciences NDRA
€ 3.02 0.87%

Quartalsbericht 2025-Q3
hinzugefügt 14.11.2025

report update icon

ENDRA Life Sciences Langfristiger Schuldenstrom 2011-2026 | NDRA

Langfristiger Schuldenstrom Jährlich ENDRA Life Sciences

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
96.9 K 174 K 152 K 132 K 76.5 K 66.2 K - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
174 K 66.2 K 116 K

Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
Centogene N.V. Centogene N.V.
CNTG
2.18 M - -6.23 % $ 30.6 M germanyGermany
Biomerica Biomerica
BMRA
358 K $ 2.13 -2.74 % $ 4.89 M usaUSA
Akumin Akumin
AKU
17.2 M - -17.87 % $ 25.9 M canadaCanada
Enzo Biochem Enzo Biochem
ENZ
841 K - -8.98 % $ 14.8 K usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
264 K - - $ 9.42 M israelIsrael
Castle Biosciences Castle Biosciences
CSTL
1.66 M $ 25.75 3.0 % $ 715 M usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
174 M $ 195.6 0.17 % $ 21.7 B usaUSA
DermTech DermTech
DMTK
3.07 M - -11.32 % $ 2.94 M usaUSA
Aspira Women's Health Aspira Women's Health
AWH
77 K - -6.19 % $ 10.5 M usaUSA
DexCom DexCom
DXCM
21.6 M $ 65.94 -1.51 % $ 25.7 B usaUSA
Co-Diagnostics Co-Diagnostics
CODX
838 K $ 4.4 101.83 % $ 129 M usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
829 K - -61.36 % $ 2.46 M usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
33.6 M $ 104.91 - $ 19.8 B usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
147 K - - $ 399 M chinaChina
Genetic Technologies Limited Genetic Technologies Limited
GENE
264 K - - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
21.5 M - 0.12 % $ 80.1 M chinaChina
Fulgent Genetics Fulgent Genetics
FLGT
1.44 M $ 16.33 5.29 % $ 494 M usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
57.7 M $ 158.0 2.86 % $ 7.83 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
93 M $ 166.96 0.54 % $ 28.7 B usaUSA
Biocept Biocept
BIOC
518 K - -13.05 % $ 7.29 M usaUSA
Invitae Corporation Invitae Corporation
NVTA
14.6 M - - $ 21.2 M usaUSA
BioNano Genomics BioNano Genomics
BNGO
697 K $ 1.46 26.96 % $ 1.86 M usaUSA
Interpace Biosciences Interpace Biosciences
IDXG
383 K $ 1.71 0.73 % $ 7.5 M usaUSA
IDEXX Laboratories IDEXX Laboratories
IDXX
27.1 M $ 578.51 0.22 % $ 46.5 B usaUSA
Illumina Illumina
ILMN
79 M $ 123.79 -0.43 % $ 19.7 B usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
24.3 M $ 100.35 0.65 % $ 8.28 B irlandaIrlanda
DarioHealth Corp. DarioHealth Corp.
DRIO
430 K $ 7.5 -6.13 % $ 29.9 M israelIsrael
Guardant Health Guardant Health
GH
27.7 M $ 84.9 -0.33 % $ 10.6 B usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
23.4 M - - $ 10.6 B niderlandNiderland
CareDx, Inc CareDx, Inc
CDNA
6.52 M $ 17.56 2.39 % $ 936 M usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
3.8 M $ 75.73 -0.92 % $ 5.11 B usaUSA
Celcuity Celcuity
CELC
172 K $ 106.75 0.67 % $ 4.21 B usaUSA
Medpace Holdings Medpace Holdings
MEDP
23.2 M $ 456.93 0.98 % $ 13.2 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
915 K - 0.22 % $ 16.8 M usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
191 M $ 264.42 0.54 % $ 22 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
169 K - -34.28 % $ 263 K israelIsrael
Mettler-Toledo International Mettler-Toledo International
MTD
35.1 M $ 1 239.07 2.87 % $ 25.5 B schweizSchweiz
Myriad Genetics Myriad Genetics
MYGN
6.9 M $ 4.66 1.75 % $ 432 M usaUSA
NeoGenomics NeoGenomics
NEO
4.78 M $ 8.1 1.76 % $ 1.04 B usaUSA
National Research Corporation National Research Corporation
NRC
451 K $ 17.51 1.1 % $ 392 M usaUSA
Natera Natera
NTRA
7.64 M $ 200.09 2.46 % $ 19.7 B usaUSA
OPKO Health OPKO Health
OPK
12.6 M $ 1.15 2.68 % $ 798 M usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
448 K $ 1.39 4.51 % $ 417 M usaUSA
RadNet RadNet
RDNT
61.9 M $ 61.74 0.41 % $ 4.64 B usaUSA
Heska Corporation Heska Corporation
HSKA
2.94 M - - $ 1.31 B usaUSA